Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-24 @ 5:44 PM
NCT ID:
NCT01734668
Eligibility Criteria:
Inclusion Criteria:
1. Male or Female
2. Children less than nineteen (19) years of age can participate (assuming appropriate consent is obtained).
3. Must currently be exhibiting symptoms characteristic of respiratory syncytial virus (RSV) illness.
4. Subjects must present with one or more of the following to be eligible for enrollment:
* Fever, ≥ 37.8º C (100º F) at present or within past 24 hours
* Moderate to severe runny nose\*
* Moderate to severe congestion\*
* Decreased appetite
* Coughing
* Sneezing\*
* Wheezing
* Irritability
* Decreased activity
* Labored breathing
Exclusion Criteria:
1. Subjects nineteen years of age or older.
2. The parent or legal guardian is unable to understand and consent to participation.
3. Current or prior treatment during this infection with anti-RSV Synagis®.
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
18 Years
Study:
NCT01734668
Study Brief:
Protocol Section:
NCT01734668